Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
80studies shown
Showing 49-60 of 80
Other study type icon
CompletedNCT02794129

fMRI of Flight of Ideas in Bipolarity

This study is completed. It focuses on bipolarity and currently lists study information in France.

In France
BipolarityOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
CHU de Reims
Condition
Bipolarity
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study is completed. It focuses on bipolarity and currently lists study information in Canada, Colombia, Czech Republic, France, India, Japan, Lithuania, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa, Ukraine, and the United States.

In France
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This study is completed. It focuses on bipolarity and currently lists study information in Czech Republic, France, Germany, India, Poland, Romania, Russian Federation, South Africa, Ukraine, and the United States.

In France
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, France, Czech Republic, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

This study is completed. It focuses on bipolarity and currently lists study information in Czech Republic, France, India, Romania, Russian Federation, South Africa, Ukraine, and the United States.

In France
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, France, Czech Republic, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01485640

Lurasidone Extended Use Study

This study is completed. It focuses on schizophrenia and currently lists study information in Canada, Colombia, Czech Republic, France, India, Lithuania, Romania, Russian Federation, Serbia, Slovakia, South Africa, and Ukraine.

In France
Schizophrenia, BipolarityOther
Countries
France, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This study is completed. It focuses on bipolarity and currently lists study information in Bulgaria, Colombia, France, Hungary, Mexico, the Philippines, Poland, the United States, South Korea, and Ukraine.

In France
Bipolarity, DepressionOtherFrom 10 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.